Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
12.66
-0.57 (-4.31%)
At close: Aug 31, 2026, 4:00 PM EDT
12.60
-0.06 (-0.47%)
After-hours: Aug 31, 2026, 7:36 PM EDT
Evommune Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Evommune stock has a consensus rating of "Buy" and an average price target of $27.63. The average 1-year stock price forecast is 118.25% higher than the current stock price, while the lowest is $22 (+73.78%) and the highest is $32 (+152.76%).
Price Target: $27.63 (+118.25%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Evommune stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 8 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 3 | 3 | 4 |
| Hold | 0 | 0 | 0 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 10 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Initiates $28 | Buy | Initiates | $28 | +121.17% | Aug 26, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $30 | Buy | Maintains | $30 | +136.97% | Aug 11, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $22 | Buy | Maintains | $22 | +73.78% | Aug 10, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $26 | Buy | Reiterates | $26 | +105.37% | Aug 10, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $30 → $29 | Buy | Maintains | $30 → $29 | +129.07% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
625.00K
from 13.00M
Decreased by -95.19%
Revenue Next Year
777.78K
from 625.00K
Increased by 24.44%
EPS This Year
-3.38
from -11.22
EPS Next Year
-3.40
from -3.38
EPS and Forward PE are based on non-GAAP adjusted numbers.